Khattak, S.; Ochoa-Ferraro, A.; Khan, N.; George, S.; Khan, S.Q.; Townend, J.N.; Dawson, C.; Thomas, M.R.
Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia. J. Clin. Med. 2025, 14, 7946.
https://doi.org/10.3390/jcm14227946
AMA Style
Khattak S, Ochoa-Ferraro A, Khan N, George S, Khan SQ, Townend JN, Dawson C, Thomas MR.
Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia. Journal of Clinical Medicine. 2025; 14(22):7946.
https://doi.org/10.3390/jcm14227946
Chicago/Turabian Style
Khattak, Sophia, Antonio Ochoa-Ferraro, Nazish Khan, Sudhakar George, Sohail Q. Khan, Jonathan N. Townend, Charlotte Dawson, and Mark R. Thomas.
2025. "Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia" Journal of Clinical Medicine 14, no. 22: 7946.
https://doi.org/10.3390/jcm14227946
APA Style
Khattak, S., Ochoa-Ferraro, A., Khan, N., George, S., Khan, S. Q., Townend, J. N., Dawson, C., & Thomas, M. R.
(2025). Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia. Journal of Clinical Medicine, 14(22), 7946.
https://doi.org/10.3390/jcm14227946
